MYCN and neuroblastoma: In agreement with their common etiology associated with defective HRR, ID6 followed the same prevalence distribution as SBS3, corroborating the predominance of defective HRR in high-risk non-MYCN-amplified neuroblastomas (p < 1.8 × 10−2).